M. Bigaud et al., STRUCTURE-ACTIVITY RELATIONSHIP OF PHOSPHORAMIDON DERIVATIVES FOR IN-VIVO ENDOTHELIN-CONVERTING-ENZYME INHIBITION, Fundamental and clinical pharmacology, 8(2), 1994, pp. 155-161
The structure activity relationship of phosphoramidon analogues was st
udied for their ability to reduce the hypertensive effect of exogenous
proET-1, probably via inhibition of an endothelin converting enzyme a
ctivity (ECE). Results concerning in vivo ECE and in vitro thermolysin
inhibitions were compared. In contrast to the phosphoryl group of pho
sphoramidon, which was found to be an absolute requirement, the rhamno
se moiety was of very little importance for the inhibition of either e
nzyme. Furthermore, the tryptophan residue of phosphoramidon appeared
to be particularly important for the ECE inhibition, whereas thermolys
in inhibition seemed to depend greatly on the leucine residue. It is c
oncluded that in vivo ECE and thermolysin differ in the way they recog
nise phosphoramidon. The existence of an hydrophobic pocket, specific
for the recognition of the tryptophan residue of phosphoramidon, could
be proposed for ECE.